Details for New Drug Application (NDA): 009112

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 009112 describes EURAX, which is a drug marketed by Journey and is included in two NDAs. Additional details are available on the EURAX profile page.

The generic ingredient in EURAX is crotamiton. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the crotamiton profile page.

Summary for 009112

Tradename:	EURAX
Applicant:	Journey
Ingredient:	crotamiton
Patents:	0
Formulation / Manufacturing:	see details

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	LOTION;TOPICAL			Strength	10%
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AT	RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.